Clinical Trials Update: June 9, 2006
Menstrual Disorders Alzheimer's Disease Diabetes - Type 1
(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:
This study will evaluate the safety of an investigational medication to treat heavy menstrual bleeding. Candidates must be women 18 to 49 with regular menstrual cycles and heavy bleeding who do not have any other bleeding disorder. The study will last approximately 28 months and involve 14 office visits.
The research sites are in Texas and Arkansas.
This study will evaluate an investigational medication for memory loss stemming from Alzheimer's disease. Candidates must be 50 to 85 and have a caregiver who can accompany the volunteer to scheduled study visits. Participants will receive physical exam, memory evaluation, and study medication at no cost. Compensation also may be provided for time and travel, including use of a car service.
The research site is in Chicago, Ill.
Diabetes - Type 1
This 52-week research study will evaluate investigational use of inhaled insulin before meals and an injection of insulin at bedtime. Candidates must be 18 to 80 who have had type 1 diabetes for at least one year and are non-smokers.
The research site is in Portland, Ore.
Copyright 2006 Thomson CenterWatch. All rights reserved.